Effects of ipragliflozin, a selective sodium–glucose co-transporter 2 inhibitor, on blood pressure in Japanese patients with type 2 diabetes mellitus: a pooled analysis of six randomized, placebo-controlled clinical trials
2016 ◽
Vol 8
(1)
◽
pp. 76-86
◽
2020 ◽
Vol 19
(9)
◽
pp. 1193-1202
◽
2018 ◽
Vol 20
(10)
◽
pp. 1527-1535
◽
Keyword(s):
2017 ◽
Vol 53
(1)
◽
pp. 140-151
◽
2017 ◽
Vol 20
(3)
◽
pp. 620-628
◽
Keyword(s):
Keyword(s):
2016 ◽
Vol Volume 12
◽
pp. 337-340
◽
Keyword(s):
2017 ◽
Vol 8
(4)
◽
pp. 397-401
◽
Keyword(s):